RAdiation Dose In percutAneuos Coronary Procedures Through TransradIal apprOach Using Dedicated radiatioN Shields (RADIATION)

January 27, 2016 updated by: Alessandro Sciahbasi, MD, Ospedale Sandro Pertini, Roma

RAdiation Dose In percutAneuos Coronary Procedures Through TransradIal apprOach Using Dedicated radiatioN Shields (The RADIATION Study)

During percutaneous coronary interventions standard operator radio-protection is generally ensured using a lead apron, a thyroid lead collar, low leaded flaps, an upper mobile leaded glass suspended from the ceiling and leaded glasses. Previous studies showed that adding a bismuth-barium radiation shield drape on the patient right arm or using a pelvic lead shield on the patient, the radiation dose adsorbed by operators was significantly reduced even if was higher compared to transfemoral approach. No studies evaluated the effect of both adjunctive shields placed in the same patient.

Aim of our randomized study is to evaluate if the combination of a shield drape on the patient right arm and a pelvic lead shield during transradial percutaneous coronary procedures may reduce the radiation dose adsorbed by operators compared to the use of only one shield or none.

All patients who underwent to percutaneous coronary diagnostic or interventional procedures will be enrolled in this randomized study. Eligible patients will be randomized (using a computer generated randomization sequence) in 4 groups:

  1. use of a pelvic shield drape
  2. use of a shield drape on the patient right arm
  3. use of a pelvic shield drape and a shield drape on the patient right arm
  4. Any adjunctive shield drape (only standard radio-protection) For each group a further internal randomization will be performed in order to compare the right or left radial transradial approach.

Each operator will be equipped with dedicated dosimeters placed at left wrist and at thorax level outside the lead apron. Since December 2013 the operators are equipped with a further dosimeter at head level.

Primary end-point of the study is the radiation dose adsorbed at wrist and thorax by operators and detected by the electronic dosimeters.

Secondary end-point are:

  1. Radiation dose adsorbed by operators according to the radial access (right versus left)
  2. Radiation dose adsorbed by the patients
  3. Radiation dose adsorbed at head level.

Study Overview

Study Type

Interventional

Enrollment (Actual)

452

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Rome, Italy
        • Ospedale Sandro Pertini - ASL RMB- UOSD Emodinamica

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

All patients who underwent to percutaneous coronary diagnostic or interventional procedures will be enrolled in this randomized study

Exclusion Criteria:

  1. Previous coronary artery by-pass
  2. Acute ST elevation myocardial infarction
  3. Hemodynamic instability or cardiogenic shock
  4. Ischemic Allen test.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Pelvic drape
Pelvic shield drape over the patient
Diagnostic coronary angiography
Percutaneous coronary intervention
Right transradial access
Left transradial access
Experimental: Arm drape
Right radial arm drape over the patient
Diagnostic coronary angiography
Percutaneous coronary intervention
Right transradial access
Left transradial access
Experimental: Pelvic and arm drape
Pelvic and arm drpaes placed over the patient
Diagnostic coronary angiography
Percutaneous coronary intervention
Right transradial access
Left transradial access
Sham Comparator: No drapes
Standard radioprotection devices
Diagnostic coronary angiography
Percutaneous coronary intervention
Right transradial access
Left transradial access

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Radiation dose adsorbed by operators
Time Frame: During procedure
Primary end-point of the study is the radiation dose adsorbed at wrist and thorax by operators and detected by the electronic dosimeters
During procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Radiation dose adsorbed by operators according to the radial access (right versus left)
Time Frame: During procedure
Radiation dose adsorbed by operators according to the radial access (right versus left)
During procedure
Radiation dose adsorbed by the patients
Time Frame: During procedure
Radiation dose adsorbed by the patients
During procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2013

Primary Completion (Actual)

December 1, 2015

Study Completion (Actual)

December 1, 2015

Study Registration Dates

First Submitted

April 19, 2013

First Submitted That Met QC Criteria

April 23, 2013

First Posted (Estimate)

April 24, 2013

Study Record Updates

Last Update Posted (Estimate)

January 28, 2016

Last Update Submitted That Met QC Criteria

January 27, 2016

Last Verified

January 1, 2016

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myocardial Ischemia

Clinical Trials on Coronary angiography

3
Subscribe